REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pt Mitra Central Asia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Mitra Central Asia Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Mitra Central Asia is based in Indonesia. The head office is in Surabaya. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on November 21, 2006. From the latest financial highlights, Pt Mitra Central Asia reported a net sales revenue increase of 11.35% in 2024. Its’ total assets recorded a growth of 10.17%.

Headquarters
Ruko Panji Makmur Blok B/7
Surabaya; East Java; Postal Code: 60299

Contact Details: Purchase the Pt Mitra Central Asia report to view the information.

Basic Information
Registered Capital:
Purchase the Pt Mitra Central Asia report to view the information.
Financial Auditors:
Purchase the Pt Mitra Central Asia report to view the information.
Incorporation Date:
November 21, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Mitra Central Asia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
11.35%▲
Total Operating Revenue
11.35%▲
Total Assets
10.17%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo